Poland vs Slovenia: HICP - Tea, mate and other plant-derived products for infusion (ND)
Poland
1.72
in 2026
Slovenia
2.18
in 2026
Poland rank
5th
Slovenia rank
2nd
HICP - Tea, mate and other plant-derived products for infusion (ND) over time
- Poland
- Slovenia
How they compare
Slovenia currently reports 2.18 against 1.72 in Poland, a difference of 0.46.
That makes Slovenia's figure about 1.3 times Poland's.
The two have swapped places 3 times across 27 shared years of data; in 2000 it was Poland ahead.
Poland ranks 5th and Slovenia ranks 2nd of 27 countries.
Across the 3 decades both report, Poland averaged higher in 2 and Slovenia in 1.
Head to head by decade
| Decade | Poland | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.62 | 1.32 | 1.3 | Poland |
| 2010s | 1.98 | 1.04 | 0.944 | Poland |
| 2020s | 1.44 | 1.59 | 0.1514 | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hicp - tea, mate and other plant-derived products for infusion (nd), Poland or Slovenia?
- Slovenia, at 2.18 against 1.72 in Poland as of 2026.
- What is the difference in hicp - tea, mate and other plant-derived products for infusion (nd) between Poland and Slovenia?
- 0.46, with Slovenia ahead.
- How many years of comparable data are there for Poland and Slovenia?
- 27 years are reported by both, from 2000 to 2026.
- How do Poland and Slovenia rank globally for hicp - tea, mate and other plant-derived products for infusion (nd)?
- Poland ranks 5th and Slovenia ranks 2nd of 27 countries.
- Where does this data come from?
- European Central Bank, published as HICP - Tea, mate and other plant-derived products for infusion (ND) (Neither seasonally nor working day adjusted, Sub-index weight). Statizoid refreshes it automatically from the source and publishes the full history for both places.